Search
for

    Sort by

    Research 121–150 of 340

    1. Comment on: Bicalutamide and the new perspectives for female pattern hair loss treatment: What dermatologists should know Journal of Cosmetic Dermatology · 2022
    2. Reply to: “Comment on: Bicalutamide Improves Minoxidil-Induced Hypertrichosis in Female Pattern Hair Loss: A Retrospective Review of 35 Patients” Journal of The American Academy of Dermatology · 2022
    3. Androgen‐induced neurite outgrowth is mediated by neuritin in motor neurones Journal of Neurochemistry · 2004 · 104 citations
    4. Visualising Androgen Receptor Activity in Male and Female Mice PloS one · 2013 · 89 citations
    5. Revising the role of the androgen receptor in breast cancer Journal of Molecular Endocrinology · 2014 · 68 citations
    6. Matriptase activation and shedding with HAI-1 is induced by steroid sex hormones in human prostate cancer cells, but not in breast cancer cells American journal of physiology. Cell physiology · 2006 · 56 citations
    7. Differential Expression of miR-93 and miR-21 in Granulosa Cells and Follicular Fluid of Polycystic Ovary Syndrome Associating with Different Phenotypes Scientific Reports · 2017 · 54 citations
    8. The antiandrogen enzalutamide downregulates TMPRSS2 and reduces cellular entry of SARS-CoV-2 in human lung cells Nature Communications · 2021 · 50 citations
    9. 5α-Reductase inhibitors, antiviral and anti-tumor activities of some steroidal cyanopyridinone derivatives International Journal of Biological Macromolecules · 2011 · 26 citations
    10. Dihydrotestosterone-induced hair regrowth inhibition by activating androgen receptor in C57BL6 mice simulates androgenetic alopecia Biomedicine & Pharmacotherapy · 2021 · 23 citations
    11. The antiandrogenic effect of finasteride against a mutant androgen receptor Cancer Biology & Therapy · 2011 · 20 citations
    12. Recent Advances in the Chemistry and Pharmacological Activity of New Steroidal Antiandrogens and 5α-Reductase Inhibitors Current Medicinal Chemistry · 2005 · 20 citations
    13. Androgen Receptor in Human Health: A Potential Therapeutic Target Current Drug Targets · 2012 · 12 citations
    14. Frontal fibrosing alopecia after antiandrogen hormonal therapy in a male patient Journal of the European Academy of Dermatology and Venereology · 2018 · 9 citations
    15. A Case of Familial Male-limited Precocious Puberty with a Novel Mutation JCRPE · 2020 · 6 citations
    16. UPDATE ON IDIOPATHIC HIRSUTISM: DIAGNOSIS AND TREATMENT Acta Clinica Belgica · 2013 · 6 citations
    17. Retrospective analysis of smell and taste disturbances associated with dermatologic medications reported to the United States Food and Drug Administration and relevance to COVID-19 infections Journal of the American Academy of Dermatology · 2020 · 5 citations
    18. Growing Up Fast: Managing Autism Spectrum Disorder and Precocious Puberty 2020 · 3 citations
    19. 5α-Reductase Inhibitors Do Not Prevent the Development and Progression of Urothelial Cancer: In Vitro Evidence Bladder cancer · 2020 · 3 citations
    20. Hirsutism: Diagnosis and Treatment Journal of metabolic syndrome · 2012 · 2 citations
    21. Pharmacology of Anti-androgens in the Skin Handbook of experimental pharmacology · 1989 · 1 citations
    22. Development and validation of a comprehensive in vitro organ model for androgenetic alopecia BMC Biotechnology · 2026
    23. (PNM-35) Recurrent priapism in a sickle cell disease patient treated with gonadotropin-releasing hormone (GnRH) agonists drugs: a case report The Journal of Sexual Medicine · 2026
    24. Should Oral Minoxidil be Our First Choice for Treatment of Alopecia? International Journal of Trichology · 2025
    25. ВЫБОР ТЕРАПИИ У ПАЦИЕНТОК С СИНДРОМОМ ПОЛИКИСТОЗНЫХ ЯИЧНИКОВ В ПОЗДНЕМ РЕПРОДУКТИВНОМ ВОЗРАСТЕ Medicine theory and practice · 2025
    26. ANDROGENINĖS ALOPECIJOS MEDIKAMENTINIO GYDYMO GALIMYBĖS Health Sciences · 2024
    27. Synthesis and application of clinically approved small-molecule drugs targeting androgen receptor Bioorganic Chemistry · 2023
    28. Polycystic ovary syndrome (multifactorial endocrinopathy): manifestation and treatment strategies Pharma innovation · 2023
    29. Caractérisation physique et chimique des substances à activité thérapeutique : application aux études de profil de stabilité et de préformulation HAL (Le Centre pour la Communication Scientifique Directe) · 2015
    30. 1408 INDUCTION OF SECRETED WNT FACTOR WISP1/CCN4 BY HUMAN PROSTATE STROMAL CELLS BY MICROENVIORNMENTAL HYPOXIA The Journal of Urology · 2010